返回 Agenda
Session Chair(s)
Yoshinobu Tanaka
Japan Clinical Director, Oncology Clinical Development, Oncology Science Unit
MSD K.K., Japan
Takeharu Yamanaka, PHD
Professor, Department of Biostatics, School of Medicine
Yokohama City University, Japan
Speaker(s)
Points to Consider: Concurrent Development of Companion Diagnostics and Corresponding New Drugs. What are Issues? Where are We? Where are We Going?
Masaaki Urata, PHD
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Reviewer, Office of New Drug V
Current Issues and Future Direction of Quality Control for Molecular Diagnostics – Challenges between IVD and LDT
Mikio Kawahara, MBA
U Tokyo IPC, Japan
Chief Investment Officer
Current Strategy for Companion Diagnostics Development in Pharmaceutical Company
Shigeru Takeshita, MSC
Astellas Pharma Inc., Japan
Manager, Clinical Pharmacology, Astellas Pharma Global Development